Zydus Cadila files investigational new drug application for COVID-19 treatment
PTI, Nov 3, 2020, 11:54 AM IST
New Delhi: Drug firm Zydus Cadila on Tuesday said it has filed the investigational new drug (IND) application for ZYIL1, positioned for management of critically ill COVID-19 patients.
“Following up on its initiatives to fight COVID-19 with diagnostics, vaccines and therapeutics, the company is now focussing on cutting edge research to bring targeted therapies… it has filed the IND application of ZYIL1, a novel oral small molecule,” the company said in a regulatory filing.
Zydus Cadila said ZYIL1 will bridge a critical unmet healthcare need in several inflammatory diseases including the current pandemic of COVID-19 and address complications caused by chronic and uncontrolled inflammation.
The company said it has completed all IND enabling preclinical studies and has filed the IND application to advance this drug candidate towards the clinic.
Zydus Cadila said ZYIL1, has demonstrated promising efficacy in a number of validated pre-clinical models of Inflammatory Bowel Disease (IBD), Multiple Sclerosis (MS), Sepsis, and acute lung injury models of Acute Respiratory Distress Syndrome (ARDS).
Shares of Cadila Healthcare were trading 7.88 percent higher at Rs 442.45 apiece on BSE.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Gunmen kill Pakistani policeman guarding polio workers
MP home minister directs DGP to file FIR against Amazon officials, owner
HC proposes to reduce costs on Juhi Chawla from Rs 20L to Rs 2L in 5G lawsuit
Related Articles More
Low-cost smartphone-based test can accurately detect COVID-19 in 20 minutes
Don’t want people’s livelihood to be affected, Covid curbs to be eased as soon as possible: Kejriwal
Shocking! Woman vaccinated four months after her death
Breakthrough COVID-19 infections generate strong antibody response: Study
Karnataka reports over 50,000 COVID-19 cases
In this UP polls, Gorakhpur gets chance to send a CM to state assembly
14 FIRs against touts, staff of Bangalore Development Authority for fraud in online plot sale
BJP leadership ‘cutting him to size’; there can only be one ‘supreme leader’: Priyanka on Adityanath fielded from Gorakhpur
Extended FCRA registration of 11,594 NGOs which applied within cut-off date, Centre tells SC
‘100 Great Chronicles of Indian History’: Book gives a peek into India’s glorious past